Skip to main content

Table 1 Demographic data pH data and endoscopic results for patients before therapy with esomeprazole at baseline assessment

From: GERD assessment including pH metry predicts a high response rate to PPI standard therapy

  Screening pH negative symptom relief 40 mg q.d. symptom relief 40 mg b.i.d. persistence
  n = 31 n = 9 n = 19 n = 2 n = 1
Gender (male/female) 12/19 0/9 9/10 2/0 1/0
Age (mean±SD) 52.4±17.1 years 47.5±3.5 years 52.5± 2.8 years 23.7± 5.1 years 66 years
Endoscopy
NERD   7 (no erosions) 7   
ERD Los Angeles A   2 4 1 1
ERD Los Angeles B    5 1  
ERD Los Angeles C    1   
Barrett’s Esophagus    2   
DeMeester score ±SD _ 5.5 ± 1.8 26.9 ± 3.9 20.9 ± 15.7 30.3
‐ DeMeester [day 1] _ 5.9 ± 2.9 28.2 ± 4.8 21.6 ± 19.8 23.2
‐ DeMeester [day 2] _ 4.9 ± 2.4 25.6 ± 3.9 10.7 ± 3.5 34.8